NS Investment
21
93M
18
2.62
0.14
6
- Areas of investment
Summary
NS Investment is the famous VC, which was founded in 2016. The fund was located in Asia if to be more exact in South Korea. The main department of described VC is located in the Seoul.
The typical case for the fund is to invest in rounds with 9-10 participants. Despite the NS Investment, startups are often financed by The Column Group, Topspin Partners, Third Rock Ventures. The meaningful sponsors for the fund in investment in the same round are The Column Group, Sofinnova Investments, OrbiMed. In the next rounds fund is usually obtained by Topspin Partners, The Column Group, Taiho Ventures.
We can highlight the next thriving fund investment areas, such as Biotechnology, Emergency Medicine. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Antiva Biosciences, Surrozen, Fulcrum Therapeutics. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 2 or 4 of the founder, the chance for it to get the investment is meager.
The top amount of exits for fund were in 2019. The important activity for fund was in 2018. Comparing to the other companies, this NS Investment performs on 14 percentage points more the average number of lead investments. The fund is constantly included in 2-6 deals per year. Deals in the range of 50 - 100 millions dollars are the general things for fund.
We also calculated 2 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 21
- Lead investments
- 0
- Exits
- 6
- Rounds per year
- 2.62
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (21)
- Therapeutics (12)
- Health Care (10)
- Medical (10)
- Pharmaceutical (6) Show 5 more
- Investments by region
- United States (20)
- South Korea (1)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 94M
- Group Appearance index
- 1.00
- Avg. company exit year
- 13
- Avg. multiplicator
- 2.36
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 3GOLDEN | 12 Jun 2007 | Information Services, Finance, Big Data | Seed | 463K | China, Beijing, Dongcheng District |
| Accent Therapeutics | 23 Jan 2024 | Biotechnology, Medical, Pharmaceutical, Therapeutics | Late Stage Venture | 75M | United States, Kentucky, Lexington |
| Aforeserve | 18 Nov 2021 | Information Technology, Cyber Security, IT Infrastructure, Information and Communications Technology (ICT) | Seed | Uttar Pradesh, Noida, India | |
| Silverback Therapeutics | 11 Mar 2020 | Biotechnology, Health Care, Medical, Therapeutics, Biopharma | Early Stage Venture | 78M | United States, Washington, Seattle |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.